340
Views
0
CrossRef citations to date
0
Altmetric
Corrigendum

Corrigendum

Figures & data

Figure 3. Placebo-adjusted, least squares mean change from baseline in SGRQ total scores in subjects receiving GLY 25 or 50 mcg b.i.d. in the GOLDEN 3 (a) and GOLDEN 4 (b) studies, and in subjects receiving GLY 50 mcg b.i.d. (57% of total population) or TIO 18 mcg q.d. (43% of total population) in the GOLDEN 5 study (c).

Figure 3. Placebo-adjusted, least squares mean change from baseline in SGRQ total scores in subjects receiving GLY 25 or 50 mcg b.i.d. in the GOLDEN 3 (a) and GOLDEN 4 (b) studies, and in subjects receiving GLY 50 mcg b.i.d. (57% of total population) or TIO 18 mcg q.d. (43% of total population) in the GOLDEN 5 study (c).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.